Literature DB >> 2457549

Polymorphism of Hh-1, the mouse hemopoietic histocompatibility locus.

R M Rembecki1, V Kumar, C S David, M Bennett.   

Abstract

The major goal of these studies is to more fully assess the polymorphism of the hemopoietic histocompatibility (Hh) genetic system. H-2 homozygosity is required for optimal immunogenicity of bone marrow cell (BMC) grafts, and "hybrid resistance" to grafts of parental strain BMC by irradiated H-2 heterozygous F1 hybrid mice suggests that Hh-1 antigens are inherited recessively. The Hh-1 antigens are also expressed on other normal hematopoietic cells and lymphoid tumors, and natural killer cells are the effectors which mediate the elimination of BMC grafts in an Hh-specific manner. Previous studies have demonstrated three different antigens mapping to the Hh-1 locus near H-2D. We test the expression of Hh-1 on BMC of all nonrecombinant H-2 haplotypes of independent origin and H-2j, a presumed natural recombinant. Hh-1 typing is based on the pattern of growth and rejection in a panel of hosts. F1 hybrids with H-2b, H-2d, and H-2k are produced and used as donors and hosts to confirm the phenotype. Grafts of b, d-, and j-haplotype marrow serve as prototypical examples of determinants that are provisionally designated as 1, 2, and 3, respectively. We describe a new determinant, 4, in the k haplotype. It is non-codominantly expressed, maps to H-2D, and is also expressed on H-2b BMC. NZW, H-2z grafts exhibit a phenotype similar to k, but express a unique determinant 5 which can be distinguished from determinant 4. This additional determinant is also expressed by the b haplotype. The d, f, and p haplotypes all express determinant 2, and grafts of j-haplotype marrow are found to express determinants 2 and 5 in addition to determinant 3. The q and r haplotypes are null for all known determinants. Finally, we describe a phenotype which is a new combination of previously described determinants: s-haplotype grafts express determinants 1, 2, and 4. The polymorphism of Hh-1 detected thus far consists of seven alleles which are combinations of five distinct determinants.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457549     DOI: 10.1007/bf00375855

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  26 in total

1.  Genetic control of resistance to allogeneic and xenogeneic bone-marrow grafts in mice.

Authors:  G Cudkowicz
Journal:  Transplant Proc       Date:  1975-06       Impact factor: 1.066

2.  Hybrid resistance to parental WB-Re bone marrow grafts. Association with genetic markers of linkage group IX.

Authors:  E Lotzová; G Cudkowicz
Journal:  Transplantation       Date:  1972-03       Impact factor: 4.939

Review 3.  Biology and genetics of hybrid resistance.

Authors:  M Bennett
Journal:  Adv Immunol       Date:  1987       Impact factor: 3.543

4.  Genetics of the murine hemopoietic-histocompatibility system: an overview.

Authors:  G Cudkowicz; I Nakamura
Journal:  Transplant Proc       Date:  1983-12       Impact factor: 1.066

5.  The role of stable complexes that repress and activate eucaryotic genes.

Authors:  D D Brown
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

6.  Abrogation of resistance to bone marrow transplantation by induction of specific tolerance in natural killer cells?

Authors:  M Waterfall; L S Rayfield; L Brent
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

7.  Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.

Authors:  W J Murphy; V Kumar; M Bennett
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

8.  Genetic control of bone marrow graft rejection. I. Determinant-specific difference of reactivity in two pairs of inbred mouse strains.

Authors:  G Cudkowicz
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

9.  Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice.

Authors:  G Cudkowicz; M Bennett
Journal:  J Exp Med       Date:  1971-12-01       Impact factor: 14.307

10.  Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice.

Authors:  G Cudkowicz; M Bennett
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

View more
  8 in total

1.  PFGE mapping and RFLP analysis of the S/D region of the mouse H-2 complex.

Authors:  W P Lafuse; D Lanning; T Spies; C S David
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Fine mapping of the crossover-sites in the C4-H-2D region of H-2 recombinant mouse strains.

Authors:  M Snoek; P C Groot; T Spies; R D Campbell; P Demant
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  New microsatellite size variants as markers for a cross-over hotspot in the C4-H-2D region.

Authors:  M Snoek; H van Vugt; P C Groot
Journal:  Mamm Genome       Date:  1994-03       Impact factor: 2.957

4.  Experimental allergic orchitis in mice. VI. Recombinations within the H-2S/H-2D interval define the map position of the H-2-associated locus controlling disease susceptibility.

Authors:  C Teuscher; D L Gasser; S R Woodward; W F Hickey
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

5.  RFLP analysis of the MHC class III region defines unique haplotypes for the non-obese diabetic, cataract Shionogi and the non-obese non-diabetic mouse strains.

Authors:  T Lund; S Shaikh; E Kendall; R D Campbell; M Hattori; S Makino; A Cooke
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

6.  Skin graft rejection by beta 2-microglobulin-deficient mice.

Authors:  M Zijlstra; H Auchincloss; J M Loring; C M Chase; P S Russell; R Jaenisch
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

7.  Identification of a subset of murine natural killer cells that mediates rejection of Hh-1d but not Hh-1b bone marrow grafts.

Authors:  C L Sentman; J Hackett; V Kumar; M Bennett
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

8.  Polymorphic Hh genes in the HLA-B(C) region control natural killer cell frequency and activity.

Authors:  D P Dubey; C A Alper; N M Mirza; Z Awdeh; E J Yunis
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.